PreciseMDX and Virchow Medical Announce Strategic Partnership to Deliver Modern Online Portal for First-of-its-Kind Liquid Companion Specimen Biobank — the Virchow Vault™
User interface designed for clinical oncologists as well as the targeted therapy research
community
Los Angeles and La Jolla, CA — December 2, 2025 — PreciseMDX, a leader in digital health
infrastructure and laboratory workflow automation, and Virchow Medical, Inc., the manufacturer
of the Crow’s Nest Biopsy Catchment System and operator of the Virchow Vault Liquid
Specimen Biorepository, announced a strategic partnership. Together, the organizations will
launch a next-generation platform, powered by PreciseMDX’s software application used by
major national clinical reference labs, to allow clinicians to order genomic tests for patients
whose biopsy Liquid Companion Specimens are stored in the Virchow Vault™. The Virchow
Vault is Virchow Medical’s new biospecimen repository that offers clinical oncologists the option
to order molecular testing for their patients whose regular formalin-fixed tissue specimen is
insufficient.
The Virchow Vault, TM is a unique biobank that stores liquid specimens generated by users of the
Crow’s Nest Biopsy Catchment System. Virchow turned to PreciseMDX to build and launch the
software infrastructure due to PreciseMDX’s reputation of creating cutting-edge software
applications for biospecimen management and workflow automation.
The partnership brings together PreciseMDX’s modern portal trusted by labs, health systems,
and life science organizations—with Virchow Medical’s unique biorepository comprised entirely
from specimens that come from dislodged tumor cells that would otherwise be wasted, are now
collected by users of the Crow’ Nest Biopsy Catchment System. The result is a unique
technology-driven solution designed to support healthcare providers, clinical oncologists,
research institutions, biopharma companies, clinical laboratories and diagnostic developers who
each have their own unique needs to better serve cancer patients, create new diagnostics and
therapeutics for known cancers and others cancer that don’t yet have targeted therapeutics.
Extending Molecular Testing and Targeted Therapy to More Patients Through Integrated
Technology
Once complete, the online portal to the Virchow Vault™, will provide users a simple interface to
the complex workflows associated with biospecimen lifecycle management, including inventory
tracking, chain-of-custody documentation, mutation analytics, metadata and real-time logistics
monitoring – applied to the unique specimen type represented by Crow’s Nest Liquid
Companion Specimens. By integrating Virchow Vault™ with PreciseMDX’s HI-Trust secure and
modern portal, clinical oncologist customers will benefit from:
• Visibility into sample collection, storage, and DNA quantity and quality of each Liquid
Companion Specimen
• Patient informed consent verification and documentation
• Automated compliance and documentation, supporting regulatory requirements
• Transparent logistics and storage workflows, showing specimen status from collection to
clinical use, reporting and eventually to research use
• Scalable digital data access capable of supporting studies from small clinical investigations to
global research programs and the development of novel diagnostics and drugs.
A Unified Vision for Targeted Therapy Availability
“Biobanking is critical to accelerating innovation in precision medicine, diagnostics, and
therapeutics,” said Mark Dorner, CEO of PreciseMDX. “By partnering with Virchow Medical,
we’re empowering clinical oncologists with a secure, modern portal that ensures fast access to
Virchow’s reliable liquid biospecimens while simplifying operational complexity.”
Virchow Medical leadership echoed the enthusiasm for the partnership.
“The Virchow Vault™ liquid specimen biorepository was designed to resolve the limitations of
tissue exhaustion following core needle biopsies,” said Alexander Arrow, MD, CEO of Virchow
Medical. “We selected PreciseMDX for the user interface because of its capabilities in delivering
robust specimen workflow applications in high-volume, HIPAA-compliant, cybersecure
environments.
About PreciseMDX
PreciseMDX delivers the industry’s most comprehensive digital health platform for diagnostic
laboratories and healthcare organizations. Through advanced automation, seamless
integrations, and patient-centric workflows, PreciseMDX empowers clinicians, labs, and life
science innovators to accelerate diagnostics and improve the patient experience.
About Virchow Medical, Inc.
Formerly known as Corramedical, Inc., Virchow’s mission is to unlock critical molecular data for
every cancer patient and enable precision medicine to save more lives. It does this by providing
clinicians with the Crow’s Nest® Biopsy Catchment System, a tool they needed to provide every
biopsy patient the opportunity to be treated with precision medicine oncologic therapy without
the use of the patient's tissue block. The company creates novel collection products (the
Crow’s Nest® Biopsy Catchment System, the Cell Wrangler TM Fine Needle Aspirate Conserver,
and the MOOS TM Multi-Omic Octagonal Scavenger) to enable Liquid Companion Specimens
(LCSs) to be made from material that would have otherwise been wasted. The LCSs are stored
in a novel biorepository, the Virchow Vault, TM to make them available for downstream diagnostic
testing. The company exists to enable healthcare providers and clinical laboratories to make
use of all the cellular resources extracted from biopsy patients without exhausting the core
tissue.
